Comparative Effectiveness Study Telerehab Versus Conventional

NCT03468868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 379

Last updated 2025-01-13

Study results available
· View outcomes & findings →

Summary

This study aims to compare the effectiveness of an exercise program delivered in a conventional facility-based format versus a telerehabilitation format, which takes place in the home. Exercise can improve mobility and perhaps decrease the rate and extent of disability in people with MS. Evidence shows that traditional, facility-based exercise training may help people with MS consistently participate in exercise or to exercise at a higher, more intense level. Despite this evidence, lack of access to facility-based exercise programs may make it difficult for people with MS to engage in exercise.Telerehabilitation (telerehab) has great potential to overcome challenges associated with facility-based programs. Telerehab can include videoconferencing, remote monitoring of signs and activity, and dissemination of specialized and individualized information via electronic mechanisms, such as smartphones and computers. Both facility-based and telerehab exercise training have yielded positive results in people with MS, but have not been compared head-to-head. The current study will fill this gap in the evidence base and compare the outcomes of delivering the same exercise interventions in a facility or in the home/community using a telerehab approach. The interventions are designed to be identical in content, with the only difference being the mode of training delivery.

Conditions

Interventions

BEHAVIORAL

Exercise program for people with MS

The intervention consists of 30 minutes of resistance training and 30 minutes of cardio three times per week for 16 weeks.

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER
  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • University of Georgia

    collaborator OTHER
  • The Cleveland Clinic

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • Marquette University

    collaborator OTHER
  • Accelerated Cure Project for Multiple Sclerosis

    collaborator OTHER
  • Patient-Centered Outcomes Research Institute

    collaborator OTHER
  • Tanner Foundation for Multiple Sclerosis

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • Shepherd Center, Atlanta GA

    lead OTHER

Principal Investigators

  • Deborah Backus, PT, PhD · Shepherd Center, Atlanta GA

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-23
Primary Completion
2023-09-12
Completion
2023-09-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03468868 on ClinicalTrials.gov